Bicyclic heterocycles as HIV integrase inhibitors
US7173022B2 · kind B2 · utility
14Cited by
0References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 26, 2005 |
| Grant date | Feb 6, 2007 |
| Priority date | — |
| Expiry date | May 26, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention encompasses a series cyclic bicyclic heterocyclic compounds of Formula I which are inhibitors of HIV integrase and prevent viral integration into human DNA. This action makes the compounds useful for treating HIV infection and AIDS. The invention also encompasses pharmaceutical compositions and methods for treating those infected with HIV
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.